Drug-Induced Alopecia Areata From Upadacitinib

被引:0
|
作者
Chang, Alexander H. [1 ]
Brownstone, Nicholas D. [1 ]
Hsu, Sylvia [1 ]
机构
[1] Temple Univ Hosp & Med Sch, Dermatol, Philadelphia, PA 19140 USA
关键词
rinvoq; alopecia areata (a.a.) treatment; jak inhibitor adverse effects; drug-induced alopecia areata; upadacitinib; SEVERE ATOPIC-DERMATITIS; DUAL EFFICACY;
D O I
10.7759/cureus.66647
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This case report describes an unexpected occurrence of alopecia areata (AA) in a 55-year-old woman undergoing treatment with upadacitinib for atopic dermatitis. This patient developed AA approximately one year into her upadacitinib treatment for atopic dermatitis. This case highlights possible upadacitinibinduced AA, which has not been reported in the literature. Not only does this case demonstrate the typical timeline for drug-induced alopecia, but it also raises questions about whether upadacitinib can cause drug- induced alopecia.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Pembrolizumab-induced alopecia areata
    Elshimy, Noah
    Blakeway, Elizabeth
    Mitra, Angana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB253 - AB253
  • [22] Ocrelizumab-induced Alopecia areata
    Seidel, Paloma
    Klotz, Luisa
    Steinbrink, Kerstin
    Boehm, Markus
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 127 - 127
  • [23] Racial characteristics of alopecia areata in the US from the National Alopecia Areata Registry
    Lee, H.
    Jung, S.
    Thompson, J.
    Qureshi, A. A.
    Cho, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S54 - S54
  • [24] Development of drug-induced psoriasiform alopecia in a pediatric patient on ustekinumab
    Mihailescu, Maria
    Cibull, Thomas
    Joyce, Joel
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (12) : 1523 - 1525
  • [25] Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
    Bourkas, Adrienn N.
    Sibbald, Cathryn
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [26] Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study
    Chiricozzi, Andrea
    Balato, Anna
    Fabbrocini, Gabriella
    Di Nardo, Lucia
    Babino, Graziella
    Rossi, Mariateresa
    Esposito, Maria
    Bertoldi, Alberto Maria
    Girolomoni, Giampiero
    Gambardella, Alessio
    Antonelli, Flaminia
    Patruno, Cataldo
    Fargnoli, Maria Concetta
    Argenziano, Giuseppe
    Peris, Ketty
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1251 - 1253
  • [27] Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
    Novielli, D.
    Foti, C.
    Principi, M.
    Mortato, E.
    Romita, P.
    Dell'Aquila, P.
    Di Leo, A.
    Ambrogio, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E8 - E10
  • [28] Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata
    Gambardella, Alessio
    Licata, Gaetano
    Calabrese, Giulia
    De Rosa, Alina
    Alfano, Roberto
    Argenziano, Giuseppe
    DERMATITIS, 2021, 32 (1S) : E85 - E86
  • [29] HAIR CHANGES FOLLOWING CYTO-TOXIC DRUG-INDUCED ALOPECIA
    FAIRLAMB, DJ
    POSTGRADUATE MEDICAL JOURNAL, 1988, 64 (757) : 907 - 907
  • [30] Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
    De la Torre-gomar, Francisco Javier
    Velasco-Amador, Juan Pablo
    Prados-Carmona, Alvaro
    Ruiz-Villaverde, Ricardo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)